CLYM vs BBOT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

CLYM

33.3
AI Score
VS
BBOT Wins

BBOT

44.3
AI Score

Investment Advisor Scores

CLYM

33score
Recommendation
SELL

BBOT

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CLYM BBOT Winner
Net Income -27.22M -98.56M CLYM
Operating Income -30.57M -106.37M CLYM
ROE -11.4% -30.5% CLYM
ROA -11.1% -26.2% CLYM
Total Assets 246.29M 376.71M BBOT
Cash 44.11M 54.06M BBOT
Current Ratio 31.45 4.69 CLYM
Free Cash Flow -25.18M -80.35M CLYM

Relative Price Performance (Last 90 Days)

CLYM 1M: +27.7% · 3M: +49.1% BBOT 1M: +3.6% · 3M: +6.9%

Current Technical Phase

CLYM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.8% over 20 days), RSI 64

RSI (14): 64.4 · Price: $16.40

BBOT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 54

RSI (14): 54.0 · Price: $9.14

Fundamentals Snapshot

Metric CLYM BBOT
Market Cap
Forward P/E -15.5 -3.8
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -0.82 -2.27
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, BBOT is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.